Evidence map›Paper›PMID 32164656›Full record

ReviewBMC endocrine disorders2020

Sociodemographic and lifestyle-related risk factors for identifying vulnerable groups for type 2 diabetes: a narrative review with emphasis on data from Europe.

Ioannis Kyrou, Constantine Tsigos, Christina Mavrogianni, Greet Cardon, Vicky Van Stappen, Julie Latomme, Jemina Kivelä, Katja Wikström, Kaloyan Tsochev, Anna Nanasi and 11 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in BMC endocrine disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 141 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed, 8 pooled it
49.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 8 syntheses or guidelines pooled it, 285 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 9 countries.

Ioannis KyrouAston Medical Research Institute, Aston Medical School, Aston University, B4 7ET, Birmingham, UK. i.kyrou@aston.ac.uk.ORCID http://orcid.org/0000-0002-6997-3439
Constantine TsigosDepartment of Nutrition and Dietetics, School of Health Science and Education Harokopio University, Athens, Greece.
Christina MavrogianniDepartment of Nutrition and Dietetics, School of Health Science and Education Harokopio University, Athens, Greece.
Greet CardonDepartment of Movement and Sports Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Vicky Van StappenDepartment of Movement and Sports Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Julie LatommeDepartment of Movement and Sports Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Jemina KiveläDepartment of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Katja WikströmDepartment of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Kaloyan TsochevDepartment of Paediatrics, Medical University Varna, Varna, Bulgaria.
Anna NanasiDepartment of Family and Occupational Medicine, University of Debrecen, Debrecen, Hungary.
Csilla SemanovaDepartment of Family and Occupational Medicine, University of Debrecen, Debrecen, Hungary.
Rocío Mateo-GallegoUnidad Clínica y de Investigación en Lípidos y Arteriosclerosis, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón (IIS Aragón) CIBERCV, Zaragoza, Spain.
Itziar Lamiquiz-MoneoUnidad Clínica y de Investigación en Lípidos y Arteriosclerosis, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón (IIS Aragón) CIBERCV, Zaragoza, Spain.
George DafoulasNational and Kapodistrian University of Athens, 17 Ag. Thoma St, 11527, Athens, Greece.
Patrick TimpelDepartment for Prevention and Care of Diabetes, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.
Peter E H SchwarzDepartment for Prevention and Care of Diabetes, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.
Violeta IotovaDepartment of Paediatrics, Medical University Varna, Varna, Bulgaria.
Tsvetalina TankovaDepartment of Diabetology, Clinical Center of Endocrinology, Medical University Sofia, Sofia, Bulgaria.
Konstantinos MakrilakisNational and Kapodistrian University of Athens, 17 Ag. Thoma St, 11527, Athens, Greece.
Yannis ManiosDepartment of Nutrition and Dietetics, School of Health Science and Education Harokopio University, Athens, Greece.
Feel4Diabetes-study Group
Ghent University · BENational and Kapodistrian University of Athens · GRMedical University of Varna · BGUniversity of Debrecen · HUHarokopio University of Athens · GRAston University · GBFinnish Institute for Health and Welfare · FITechnische Universität Dresden · DEUniversidad de Zaragoza · ESUniversity Hospital Coventry · GB

Funding

European Union Horizon 2020 research and innovation programme 643708
6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM) comprises the vast majority of all diabetes cases in adults, with alarmingly increasing prevalence over the past few decades worldwide. A particularly heavy healthcare burden of diabetes is noted in Europe, where 8.8% of the population aged 20-79 years is estimated to have diabetes according to the International Diabetes Federation. Multiple risk factors are implicated in the pathogenesis of T2DM with complex underlying interplay and intricate gene-environment interactions. Thus, intense research has been focused on studying the role of T2DM risk factors and on identifying vulnerable groups for T2DM in the general population which can then be targeted for prevention interventions.

methodsFor this narrative review, we conducted a comprehensive search of the existing literature on T2DM risk factors, focusing on studies in adult cohorts from European countries which were published in English after January 2000.

resultsMultiple lifestyle-related and sociodemographic factors were identified as related to high T2DM risk, including age, ethnicity, family history, low socioeconomic status, obesity, metabolic syndrome and each of its components, as well as certain unhealthy lifestyle behaviors. As Europe has an increasingly aging population, multiple migrant and ethnic minority groups and significant socioeconomic diversity both within and across different countries, this review focuses not only on modifiable T2DM risk factors, but also on the impact of pertinent demographic and socioeconomic factors.

conclusionIn addition to other T2DM risk factors, low socioeconomic status can significantly increase the risk for prediabetes and T2DM, but is often overlooked. In multinational and multicultural regions such as Europe, a holistic approach, which will take into account both traditional and socioeconomic/socioecological factors, is becoming increasingly crucial in order to implement multidimensional public health programs and integrated community-based interventions for effective T2DM prevention.

Indexed as

Life StyleVulnerable PopulationsDiabetes Mellitus, Type 2EuropeHumansObesityPrediabetic StatePrevalenceRisk FactorsSocioeconomic FactorsDietEthnicityLifestyleObesityRisk factorsSocioeconomic statusType 2 diabetes

Identifiers

PMID32164656
PMCPMC7066728
OpenAlexW3011788268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.